Vascular endothelial growth factors (VEGF) and VEGF receptor expression as predictive biomarkers for benefit with bevacizumab in metastatic colorectal cancer (mCRC): Analysis of the phase III MAX study.
A. J. Weickhardt
Research Funding - Roche
D. Williams
No relevant relationships to disclose
C. Lee
No relevant relationships to disclose
J. Simes
Research Funding - Roche
C. Murone
No relevant relationships to disclose
K. Wilson
No relevant relationships to disclose
M. Cummins
Other Remuneration - Roche
K. Asadi
No relevant relationships to disclose
T. J. Price
Consultant or Advisory Role - Roche (U)
Research Funding - Roche
J. Mariadason
No relevant relationships to disclose
N. C. Tebbutt
Consultant or Advisory Role - Roche (U)
Research Funding - Roche